The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
A Randomized, Double-Blinded, Placebo-Controlled Multicenter Trial of Etanercept in the Treatment of Alcoholic Hepatitis
Open accessAbstract
Background Alcoholic hepatitis is a cause of major morbidity and mortality that lacks effective therapies. Both experimental and clinical evidence indicate that the multifunctional cytokine tumor necrosis factor-α (TNFα) contributes to pathogenesis and clinical sequelae of alcoholic hepatitis. A pilot study demonstrated that the TNFα-neutralizing molecule, etanercept, could be an effective treatment for patients with alcoholic hepatitis. Methods Forty-eight patients with moderate to severe alcoholic hepatitis (MELD score ≥15) were enrolled and randomized to groups that were given up to 6 subcutaneous injections of either etanercept or placebo for three weeks. Primary study endpoints included mortality at 1- and 6-month timepoints. Results There were no significant baseline differences between the placebo and etanercept groups in demographics or disease severity parameters including age, gender, and MELD score. The 1-month mortality rates of patients receiving placebo and etanercept were similar on an intention-to-treat basis (22.7% versus 36.4%, respectively; OR and 95% CI: 1.8 and 0.5–6.5). The 6-month mortality rate was significantly higher in the etanercept group, compared with the placebo group (57.7% versus 22.7%, respectively; OR and 95% CI: 4.6 and 1.3–16.4, p=0.017). Rates of infectious serious adverse events were significantly higher in the etanercept group, compared with the placebo group (34.6% versus 9.1%, p=0.04). Conclusion In patients with moderate to severe alcoholic hepatitis, etanercept was associated with a significantly higher mortality rate after 6 months, indicating that etanercept is not effective for the treatment of patients with alcoholic hepatitis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Etanercept Therapy in Rheumatoid Arthritis: A Randomized, Controlled Trial
Moreland, L. W., Schiff, M. H., Baumgartner, S. W., Tindall, E. A., Fleischmann, R. M., Bulpitt, K. J., Weaver, A. L., Keystone, E. C., Furst, D. E., Mease, P. J., et al. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-130-6-199903160-00004 · Cited by 1,379
Cytokines in Alcoholic and Nonalcoholic Steatohepatitis
Tilg, H., & Diehl, A. M. (2000) · New England Journal of Medicine · doi:10.1056/nejm200011163432007 · Cited by 948
Etanercept for active Crohn's disease: A randomized, double-blind, placebo-controlled trial
Sandborn, W. J., Hanauer, S. B., Katz, S., Safdi, M., Wolf, D. G., Baerg, R. D., Tremaine, W. J., Johnson, T., Diehl, N. N., & Zinsmeister, A. R. (2001) · Gastroenterology · doi:10.1053/gast.2001.28674 · Cited by 910
Akriviadis, E., Botla, R., Briggs, W., Han, S., Reynolds, T., & Shakil, O. (2000) · Gastroenterology · doi:10.1053/gast.2000.20189 · Cited by 800
Roach, D. R., Bean, A. G. D., Demangel, C., France, M. P., Briscoe, H., & Britton, W. J. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.9.4620 · Cited by 782
Treatment of Ankylosing Spondylitis by Inhibition of Tumor Necrosis Factor α
Gorman, J. D., Sack, K. E., & Davis, J. C. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012664 · Cited by 704
Essential role of tumor necrosis factor α in alcohol-induced liver injury in mice
Yin, M., Wheeler, M. D., Kono, H., Bradford, B. U., Gallucci, R. M., Luster, M. I., & Thurman, R. G. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70354-9 · Cited by 701
Leist, M., Gantner, F., Bohlinger, I., Tiegs, G., Germann, P., & Wendel, A. (1995) · Europe PMC (PubMed Central) · Cited by 537
MELD accurately predicts mortality in patients with alcoholic hepatitis†
Dunn, W., Jamil, L. H., Brown, L. S., Wiesner, R. H., Kim, W. R., Menon, K. V. N., Malinchoc, M., Kamath, P. S., & Shah, V. (2005) · Hepatology · doi:10.1002/hep.20503 · Cited by 530
Self-citationCarithers, R. L., Herlong, H. F., Diehl, A. M., Shaw, E. W., Combes, B., Fallon, H. J., & Maddrey, W. C. (1989) · Annals of Internal Medicine · doi:10.7326/0003-4819-110-9-685 · Cited by 504
TREATMENT OF ANKYLOSING SPONDYLITIS BY INHIBITION OF TUMOR NECROSIS FACTOR a
Orman, D., Enneth, K., Ack, E. S., Ohn, J., & Avis, C. D. (2002) · Cited by 470
Mato, J. M., Cámara, J., Paz, J. F. D., Caballería, L., Coll, S., Caballero, A., García-Buey, L., Beltrán, J., Benita, V., Caballería, J., et al. (1999) · Journal of Hepatology · doi:10.1016/s0168-8278(99)80263-3 · Cited by 463
Naveau, S., Chollet-Martin, S., Dharancy, S., Mathurin, P., Jouet, P., Piquet, M.-A., Davion, T., Oberti, F., Broët, P., & Emilie, D. (2004) · Hepatology · doi:10.1002/hep.20206 · Cited by 446
Model for end stage liver disease score predicts mortality across a broad spectrum of liver disease
SAID, A. (2004) · Journal of Hepatology · doi:10.1016/j.jhep.2004.02.010 · Cited by 437
Antibodies to tumor necrosis factor-alpha inhibit liver regeneration after partial hepatectomy
Akerman, P., Cote, P., Yang, S. Q., McClain, C., Nelson, S., Bagby, G. J., & Diehl, A. M. (1992) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1992.263.4.g579 · Cited by 401
Self-citationCabré, E., Rodríguez-Iglesias, P., Caballería, J., Quer, J. C., Sánchez-Lombraña, J. L., Parés, A., Papo, M., Planas, R., & Gassull, M. A. (2000) · Hepatology · doi:10.1053/jhep.2000.8627 · Cited by 378
[Etanercept for therapy of rheumatoid arthritis].
Miyasaka, N. (2005) · PubMed · Cited by 367
Mathurin, P., Mendenhall, C. L., Carithers, R. L., Ramond, M.-J., Maddrey, W. C., Garstide, P., Rueff, B., Naveau, S., Chaput, J.-C., & Poynard, T. (2002) · Journal of Hepatology · doi:10.1016/s0168-8278(01)00289-6 · Cited by 353
Mendenhall, C. L., Moritz, T. E., Roselle, G. A., Morgan, T. R., Nemchausky, B. A., Tamburro, C. H., Schiff, E. R., McClain, C. J., Marsano, L. S., Allen, J. I., et al. (1993) · Hepatology · doi:10.1002/hep.1840170407 · Cited by 296
Self-citationTNF-? gene polymorphism: Clinical and biological implications
Hajeer, A. H., & Hutchinson, I. V. (2000) · Microscopy Research and Technique · doi:10.1002/1097-0029(20000801)50:3<216::aid-jemt5>3.0.co;2-q · Cited by 274
Alcoholic liver disease: proposed recommendations for the American College of Gastroenterology
McCullough, A. (1998) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(98)00468-7 · Cited by 271
Alcoholic liver disease: New insights in pathogenesis lead to new treatments
Lieber, C. S. (2000) · Journal of Hepatology · doi:10.1016/s0168-8278(00)80420-1 · Cited by 260
Anti-tumor necrosis factor-alpha monoclonal antibody therapy in severe alcoholic hepatitis
Tilg, H., Jalan, R., Kaser, A., Davies, N. A., Offner, F. A., Hodges, S. J., Ludwiczek, O., Shawcross, D., Zoller, H., Alisa, A., et al. (2003) · Journal of Hepatology · doi:10.1016/s0168-8278(02)00442-7 · Cited by 232
Srikureja, W., Kyulo, N. L., Runyon, B. A., & Hu, K.-Q. (2005) · Journal of Hepatology · doi:10.1016/j.jhep.2004.12.022 · Cited by 227
Spahr, L., Rubbia-Brandt, L., Frossard, J.-L., Giostra, E., Rougemont, A.-L., Pugin, J., Fischer, M., Egger, H., & Hadengue, A. (2002) · Journal of Hepatology · doi:10.1016/s0168-8278(02)00230-1 · Cited by 214
Yamada, Y., & Fausto, N. (1998) · Europe PMC (PubMed Central) · Cited by 208
Sheth, M., Riggs, M., & Patel, T. (2002) · BMC Gastroenterology · doi:10.1186/1471-230x-2-2 · Cited by 191
Self-citationPathogenesis, Diagnosis, and Treatment of Alcoholic Liver Disease
Menon, K. V., Gores, G. J., & Shah, V. H. (2001) · Mayo Clinic Proceedings · doi:10.4065/76.10.1021 · Cited by 149
Self-citationA Pilot Study of the Safety and Tolerability of Etanercept in Patients with Alcoholic Hepatitis
Menon, K. V. N., Stadheim, L. M., Kamath, P. S., Wiesner, R. H., Gores, G. J., Peine, C. J., & Shah, V. H. (2004) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2004.04034.x · Cited by 127
Self-citationDouble-Blind, Controlled Trial of Propylthiouracil in Patients with Severe Acute Alcoholic Hepatitis
Hallé, P., Paré, P., Kaptein, E. M., Kanel, G. C., Redeker, A. G., & Reynolds, T. B. (1982) · Gastroenterology · doi:10.1016/s0016-5085(82)80257-6 · Cited by 123
Experience with etanercept in an academic medical center: Are infection rates increased?
Phillips, K., Husni, M. E., Karlson, E. W., & Coblyn, J. S. (2002) · Arthritis Care & Research · doi:10.1002/art1.10243 · Cited by 121
Cytokines--central factors in alcoholic liver disease.
Neuman, M. G. (2003) · PubMed Central · Cited by 119
Latvala, J., Hietala, J., Koivisto, H., Järvi, K., ANTTILA, P., & Niemelä, O. J. (2005) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2005.41509.x · Cited by 93
Steensma, D. P., Mesa, R. A., Li, C., Gray, L. A., & Tefferi, A. (2002) · Blood · doi:10.1182/blood.v99.6.2252 · Cited by 87
Gallucci, R. M., Simeonova, P. P., Toriumi, W., & Luster, M. I. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.2.872 · Cited by 73
Morgan, T. R. M., Weiss, D. G., Nemchausky, B. A., Schiff, E. R., Anand, B., Simon, F. R., Kidao, J., Cecil, B. D., Mendenhall, C. L., Nelson, D. B., et al. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.01.057 · Cited by 71
Self-citationLechner, A. J., VELASQUEZ, A., KNUDSEN, K. R., Johanns, C. A., Tracy, T. F., & Matuschak, G. M. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.157.5.9709067 · Cited by 63
Failure of colchicine to improve short-term survival in patients with alcoholic hepatitis
Akriviadis, E. A., Steindel, H., Pinto, P. C., Fong, T., Kanel, G. C., Reynolds, T. B., & Gupta, S. (1990) · Gastroenterology · doi:10.1016/0016-5085(90)90973-5 · Cited by 60
McClain, C. J., Barve, S. S., Joshi‐Barve, S., Song, Z., Deaciuc, I. V., Chen, T., & Hill, D. B. (2005) · Alcoholism Clinical and Experimental Research · doi:10.1097/01.alc.0000189276.34230.f5 · Cited by 57
Self-citationBird, G. L. A., Prach, A. T., McMahon, A. D., Forrest, J. A. H., Mills, P. R., & Danesh, B. J. (1998) · Journal of Hepatology · doi:10.1016/0168-8278(88)80005-9 · Cited by 49
Pentoxifylline and alcoholic hepatitis
Morgan, T. R. M., & McClain, C. J. (2000) · Gastroenterology · doi:10.1053/gast.2000.20826 · Cited by 23
Self-citationCellular Signaling Mechanisms in Alcohol-Induced Liver Damage
Hoek, J., & Pastorino, J. (2004) · Seminars in Liver Disease · doi:10.1055/s-2004-832939 · Cited by 4
Cited by
Alcoholic Liver Disease: Pathogenesis and New Therapeutic Targets
Gao, B., & Bataller, R. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.09.002 · Cited by 1,963
O'Shea, R. S., Dasarathy, S., & McCullough, A. J. (2010) · Hepatology · doi:10.1002/hep.23258 · Cited by 1,077
EASL Clinical Practice Guidelines: Management of alcohol-related liver disease
Thursz, M., Gual, A., Lackner, C., Mathurin, P., Moreno, C., Spahr, L., Sterneck, M., & Cortez-Pinto, H. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.03.018 · Cited by 943
Crabb, D. W., Im, G. Y., Szabo, G., Mellinger, J. L., & Lucey, M. R. (2020) · Hepatology · doi:10.1002/hep.30866 · Cited by 922
Lucey, M. R., Mathurin, P., & Morgan, T. R. (2009) · New England Journal of Medicine · doi:10.1056/nejmra0805786 · Cited by 863
Metadata
- Authors
- Boetticher, N. C., Peine, C. J., Kwo, P., Abrams, G. A., Patel, T., Aqel, B., Boardman, L., Gores, G. J., Harmsen, W. S., McClain, C. J., Kamath, P. S., & Shah, V. H.
- Venue
- Gastroenterology
- Publisher
- Elsevier BV
- Published
- 2008-12
- Volume
- 135
- Issue
- 6
- Pages
- 1953-1960
- ISSN
- 0016-5085 (ISSN-L)
- OpenAlex
- W2152084270
- Cited by
- 340
- References
- 42
- FWCI
- 14.11
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.